Neuropilin 1 Antikörper (AA 22-131)
Kurzübersicht für Neuropilin 1 Antikörper (AA 22-131) (ABIN1327097)
Target
Alle Neuropilin 1 (NRP1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 22-131
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant NRP1.
-
Sequenz
- FRNDKCGDTI KIESPGYLTS PGYPHSYHPS EKCEWLIQAP DPYQRIMINF NPHFDLEDRD CKYDYVEVFD GENENGHFRG KFCGKIAPPP VVSSGPFLFI KFVSDYETHG
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- NRP1 (NP_003864, 22 a.a. ~ 131 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy." in: International journal of cancer. Journal international du cancer, Vol. 128, Issue 1, pp. 119-31, (2010) (PubMed).
: "Bioinformatics methods for prioritizing serum biomarker candidates." in: Clinical chemistry, Vol. 52, Issue 11, pp. 2162-4, (2007) (PubMed).
: "
-
Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy." in: International journal of cancer. Journal international du cancer, Vol. 128, Issue 1, pp. 119-31, (2010) (PubMed).
-
- Neuropilin 1 (NRP1)
-
Andere Bezeichnung
- NRP1
-
Hintergrund
-
Full Gene Name: neuropilin 1
Synonyms: BDCA4,CD304,DKFZp686A03134,DKFZp781F1414,NP1,NRP,VEGF165R -
Gen-ID
- 8829
-
NCBI Accession
- NM_003873
-
Pathways
- Regulation of Cell Size, Signaling Events mediated by VEGFR1 and VEGFR2, Smooth Muscle Cell Migration, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals
Target
-